ArticleMolecular and clinical oncology2020

HER2-positive breast cancer that resists therapeutic drugs and ionizing radiation releases sphingomyelin-based molecules to circulating blood serum.

Satoru Monzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.